Europe’s Top Pharma Marketing Leaders set to meet in London next month

On Sep 25, 2019

eyeforpharma’s Marketing and Customer Innovation Europe (15-16 October) will bring together senior pharma executives across Marketing, Digital, CX, Brand, Product, IT/CRM and Business Partnership/Technology pharma executives, to learn how to transform your customer engagement.

Join attendees on 15-16 October in London from Janssen, GSK, Sanofi, Takeda, Boehringer Ingelheim, Bristol-Myers Squibb, Novartis and more as we unite pharma marketing and harness customer insights to deliver value.

70% of attendees are from top pharma, with senior execs including

Head of Digital and BI
VP, Commercial Excellence
Business Unit Director
Head of Regional Marketing EMEA
Head of Customer Engagement
Head of MCM

and many more…

Here’s what last year’s attendees thought of the summit:

“Very inspiring place to take the pulse, understand the trends that will drive value in Life Sciences and how digital can transform the future of Pharma,” Multichannel Excellence and Strategy & Planning Director, Biogen
“I thought the conference had a very diverse audience which allowed for more perspectives than I was expecting,” Director, Multi-Channel Marketing, GSK

Confirmed speakers include: Anders Dyhr Toft, Corporate VP, Commercial Innovation, Novo Nordisk; Maria Raad, VP Customer and Digital Strategy, Janssen; Francesca Wuttke, Chief Digital Officer, Almirall; Philippe Barrilon, VP Head of Insights and Analytics, Takeda; and Bharat Tewarie, Executive Vice President and Chief Marketing Officer, UCB.

For more information visit the website: www.eyeforpharma.com/marketing or contact Blair Gottscho on blair@eyeforpharma.com.

*****

eyeforpharma provides a hub for senior-level pharma executives, patient advocacy groups and other health experts to exchange ideas and stay up-to-date with shifting trends and practices. We provide commentary, events, reports, and other valuable expert-driven content. We want to facilitate positive change through discussion and debate, enable dialogue and drive the positive benefits that pharmaceuticals can offer. We actively respond to the aims and interests of our audience, so please get in touch if you think we can do even more.